Table 3.
Salivary gland function and stomatological characteristics of the studies and control groups.
| Group | p-Value | |||||||
|---|---|---|---|---|---|---|---|---|
| C | HS | IS | ANOVA | HS vs. C | IS vs. C | IS vs. HS | ||
| n = 30 | n = 15 | n = 15 | ||||||
| SFR (mL/min) | NWS* | 0.34 ± 0.09 [0.31 - 0.37] |
0.39 ± 0.26 [0.24 - 0.52] |
0.47 ± 0.25 [0.34 - 0.61] |
0.1028 | 0.7393 | 0.084 | 0.4339 |
| SWS* | 0.91 ± 0.26 [0.82 - 1.01] |
0.63 ± 0.25 [0.5 - 0.77] |
0.69 ± 0.29 [0.54 - 0.87] |
0.0022 | 0.0039 | 0.0335 | 0.7732 | |
| TPC (μg/mL) |
NWS* | 1121 ± 188.4 [1050 - 1191] |
904.5 ± 246.6 [768 - 1041] |
817 ± 1 68.7 [723.5 - 910.4] |
< 0.0001 | 0.0033 | < 0.0001 | 0.4587 |
| SWS* | 1240 ± 166.4 [1178 - 1303] |
883.6 ± 250 [745.1 - 1022] |
952.4 ± 225.4 [827.6 - 1077] |
< 0.0001 | < 0.0001 | 0.0001 | 0.6295 | |
| DMFT* | 24.63 ± 7.25 [21.92 - 27.34] |
22 ± 9.67 [16.64 - 27.36] |
24.27 ± 3.84 [22.14 - 26.4] |
0.5123 | 0.494 | 0.9862 | 0.674 | |
| GI* | 0.74 ± 0.79 [0.44 - 1.04] |
0.91 ± 0.77 [0.49 - 1.33] |
0.6 ± 0.61 [0.26 - 0.94] |
0.522 | 0.7598 | 0.8128 | 0.4906 | |
| PlI* | 1.28 ± 1 [0.89 - 1.67] |
1.45 ± 0.94 [0.93 - 1.96] |
1.01 ± 0.9 [0.51 - 1.51] |
0.464 | 0.8551 | 0.6607 | 0.4402 | |
Results were analyzed using ANOVA analysis of variance followed by Tukey’s post hoc test; C, Control group (n = 30); DMFT, dental caries experience; GI, Gingival Index; HS, hemorrhagic stroke group (n = 15); IS, ischemic stroke group (n = 15); n, number of patients; NWS, non-stimulated whole saliva; PlI, Plaque Index; SFR, salivary flow rate; SWS, stimulated whole saliva; TPC, total protein content.
*Expressed as mean ± standard deviation (SD) [95% confidence interval (95% CI)].